Quibim is a healthtech company pioneering tools that unlock imaging data to improve patient outcomes. Quibim is at the forefront of imaging biomarkers research in life sciences, driving the development of advanced algorithms that transform imaging data into actionable predictions in oncology, immunology, and neurology. Their main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers. They share an ambition to transform healthcare and improve human lives through AI-guided precision solutions.